Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B G Redman

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Cancer|July 1, 1994
Oral etoposide in the treatment of hormone-refractory prostate cancerM H Hussain, K J Pienta, B G Redman, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|August 1, 1995
Phase I trial of sequential cyclophosphamide, cyclosporin A, and interferon-alpha in patients with cancer: attempt to induce autologous graft-versus-host reaction to elicit an antitumor responseB G Redman, T H Chou, M Zalupski, et al.
American Journal of Clinical Oncology|August 1, 1995
Phase I study of monoclonal antibody-ricin A chain immunoconjugate Xomazyme-791 in patients with metastatic colon cancerP M LoRusso, P L Lomen, B G Redman, et al.
American Journal of Clinical Oncology|August 1, 1992
Effect of calcium replacement on the hemodynamic changes associated with high dose interleukin-2 therapyB G Redman, L Flaherty, S Martino, et al.
Investigational New Drugs|August 1, 1992
Difluorodeoxycytidine (dFdC)--gemcitabine: a phase I studyE A Poplin, T Corbett, L Flaherty, et al.
Urology|August 11, 1998
A phase II trial of oral diethylstilbesterol as a second-line hormonal agent in advanced prostate cancerD C Smith, B G Redman, L E Flaherty, et al.
Journal of the National Cancer Institute|January 17, 1990
Phase II trial of high-dose intermittent interleukin-2 in metastatic renal cell carcinoma: a Southwest Oncology Group studyR M Bukowski, P Goodman, E D Crawford, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|February 1, 1993
Immunotherapy for metastatic renal cell cancer: effect on the primary tumorG P Haas, B G Redman, V K Rao, et al.
Cancer Research|September 15, 1990
Antitumor efficacy of interleukin-2 alone and in combination with adriamycin and dacarbazine in murine solid tumor systemsP M LoRusso, S L Aukerman, L Polin, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|July 1, 1992
Phase I trial of recombinant macrophage colony-stimulating factor by rapid intravenous infusion in patients with cancerB G Redman, L Flaherty, T H Chou, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Cancer|July 1, 1994
Oral etoposide in the treatment of hormone-refractory prostate cancerM H Hussain, K J Pienta, B G Redman, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|August 1, 1995
Phase I trial of sequential cyclophosphamide, cyclosporin A, and interferon-alpha in patients with cancer: attempt to induce autologous graft-versus-host reaction to elicit an antitumor responseB G Redman, T H Chou, M Zalupski, et al.
American Journal of Clinical Oncology|August 1, 1995
Phase I study of monoclonal antibody-ricin A chain immunoconjugate Xomazyme-791 in patients with metastatic colon cancerP M LoRusso, P L Lomen, B G Redman, et al.
American Journal of Clinical Oncology|August 1, 1992
Effect of calcium replacement on the hemodynamic changes associated with high dose interleukin-2 therapyB G Redman, L Flaherty, S Martino, et al.
Investigational New Drugs|August 1, 1992
Difluorodeoxycytidine (dFdC)--gemcitabine: a phase I studyE A Poplin, T Corbett, L Flaherty, et al.
Urology|August 11, 1998
A phase II trial of oral diethylstilbesterol as a second-line hormonal agent in advanced prostate cancerD C Smith, B G Redman, L E Flaherty, et al.
Journal of the National Cancer Institute|January 17, 1990
Phase II trial of high-dose intermittent interleukin-2 in metastatic renal cell carcinoma: a Southwest Oncology Group studyR M Bukowski, P Goodman, E D Crawford, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|February 1, 1993
Immunotherapy for metastatic renal cell cancer: effect on the primary tumorG P Haas, B G Redman, V K Rao, et al.
Cancer Research|September 15, 1990
Antitumor efficacy of interleukin-2 alone and in combination with adriamycin and dacarbazine in murine solid tumor systemsP M LoRusso, S L Aukerman, L Polin, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|July 1, 1992
Phase I trial of recombinant macrophage colony-stimulating factor by rapid intravenous infusion in patients with cancerB G Redman, L Flaherty, T H Chou, et al.
Pageof 4